Exelixis, Inc. (EXEL) Financial Statements
Exelixis, Inc. (EXEL) reported trailing twelve-month revenue of $2.4B (up 9.2% year on year) and net income of $860.6M as of 2026-07-03, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $1.2B.
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
EXELExelixis, Inc.Follow EXEL — free
—
Price chart with a free account
- Market cap
- 16.0B
- P/E TTM
- 20.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Jan 20 | FY2020 Jan 21 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Jan 25 | FY2025 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.29 | 0.05 | 0.03 | 0.03 | 0.04 | 0.19 | 0.45 | 0.85 | 0.97 | 0.99 | 1.43 | 1.61 | 1.83 | 2.17 | 2.32 | 2.44 | |
| Gross profit | — | — | 0.03 | 0.02 | 0.03 | 0.18 | 0.44 | 0.83 | 0.93 | 0.95 | 1.38 | 1.55 | 1.76 | 2.09 | 2.24 | — | |
| Research & development | 0.16 | 0.13 | 0.18 | 0.19 | 0.10 | 0.10 | 0.11 | 0.18 | 0.34 | 0.55 | 0.69 | 0.89 | 1.04 | 0.91 | 0.83 | 0.82 | |
| Operating income | 0.09 | -0.12 | -0.20 | -0.22 | -0.12 | -0.03 | 0.17 | 0.44 | 0.37 | 0.11 | 0.29 | 0.20 | 0.17 | 0.60 | 0.87 | 0.97 | |
| Pre-tax income | 0.08 | -0.15 | -0.24 | -0.26 | -0.16 | -0.07 | 0.16 | 0.45 | 0.40 | 0.13 | 0.29 | 0.23 | 0.26 | 0.68 | 0.94 | 1.04 | |
| Income tax | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 | -0.24 | 0.08 | 0.02 | 0.06 | 0.05 | 0.05 | 0.16 | 0.16 | 0.17 | |
| Net income | 0.08 | -0.15 | -0.24 | -0.26 | -0.16 | -0.07 | 0.15 | 0.69 | 0.32 | 0.11 | 0.23 | 0.18 | 0.21 | 0.52 | 0.78 | 0.86 | |
| Diluted EPS ($) | 0.58 | -0.91 | -1.29 | -1.34 | -0.77 | -0.28 | 0.49 | 2.21 | 1.02 | 0.35 | 0.72 | 0.56 | 0.65 | 1.76 | 2.78 | 3.18 | |
| Diluted shares (bn) | 0.130 | 0.160 | 0.184 | — | 0.209 | 0.251 | 0.312 | 0.313 | 0.315 | 0.318 | 0.322 | 0.325 | 0.321 | 0.296 | 0.282 | — |
USD billions · SEC XBRL
Exelixis, Inc. — questions
- What is Exelixis, Inc.'s revenue?
- $2.4B over the twelve months to 2026-07-03, up 9.2% year on year, from its 10-Q and 10-K filings.
- What is Exelixis, Inc.'s net income?
- $860.6M over the twelve months to 2026-07-03.
- What is Exelixis, Inc.'s free cash flow?
- $1.2B over the twelve months to 2026-07-03.
- What are Exelixis, Inc.'s diluted earnings per share?
- $3.18 over the twelve months to 2026-07-03.
Every figure on this page comes from Exelixis, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.